Cranbrook Wealth Management’s Kyndryl KD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.35K Sell
209
-7
-3% -$89 ﹤0.01% 346
2026
Q2
$2.44K Hold
216
– – ﹤0.01% 370
2026
Q1
$2.83K Hold
216
– – ﹤0.01% 344
2025
Q4
$5.74K Hold
216
– – ﹤0.01% 331
2025
Q3
$6.49K Hold
216
– – ﹤0.01% 326
2025
Q2
$9.06K Hold
216
– – ﹤0.01% 303
2025
Q1
$6.78K Hold
216
– – ﹤0.01% 300
2024
Q4
$7.47K Hold
216
– – ﹤0.01% 286
2024
Q3
$4.96K Sell
216
-62
-22% -$1.51K ﹤0.01% 303
2024
Q2
$7.32K Hold
278
– – ﹤0.01% 260
2024
Q1
$6.05K Hold
278
– – ﹤0.01% 249
2023
Q4
$5.78K Sell
278
-166
-37% -$2.84K ﹤0.01% 257
2023
Q3
$6.7K Hold
444
– – ﹤0.01% 245
2023
Q2
$5.9K Hold
444
– – ﹤0.01% 248
2023
Q1
$6.55K Hold
444
– – ﹤0.01% 247
2022
Q4
$4.94K Sell
444
-30
-6% -$302 ﹤0.01% 252
2022
Q3
$4K Hold
474
– – ﹤0.01% 273
2022
Q2
$5K Sell
474
-10
-2% -$116 ﹤0.01% 269
2022
Q1
$6K Buy
484
+18
+4% +$271 ﹤0.01% 296
2021
Q4
$8K Buy
+466
New +$10.1K ﹤0.01% 294

Other funds holding KD

Cranbrook Wealth Management's KD Position: Q3 2026 in Review

Cranbrook Wealth Management reduced its Kyndryl (KD) stake by 3.2% in Q3 2026, selling an estimated $89 and leaving 209 shares worth $2.35K. The position accounts for ﹤0.01% of the portfolio, ranked #346.

Cranbrook Wealth Management first reported a position in KD in Q4 2021 and has held it in 20 quarters since. The position peaked at $9.06K in Q2 2025. 402 funds tracked by Wall St. Rank hold KD as of Q3 2026.

  • Cranbrook Wealth Management held 209 shares of Kyndryl worth $2.35K as of Q3 2026.
  • Cranbrook Wealth Management sold 7 Kyndryl shares in Q3 2026, an estimated $89.
  • Kyndryl made up ﹤0.01% of Cranbrook Wealth Management's portfolio in Q3 2026, its #346 holding.
  • Cranbrook Wealth Management first reported a position in Kyndryl in Q4 2021 and has held it in 20 quarters since.
  • Cranbrook Wealth Management's Kyndryl position peaked at $9.06K in Q2 2025.
  • 402 funds tracked by Wall St. Rank held Kyndryl as of Q3 2026.

Based on Cranbrook Wealth Management's 13F filing for Q3 2026, filed 28 Oct 2026.